These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 31248522)
21. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. Sethi V; Vitiello GA; Saxena D; Miller G; Dudeja V Gastroenterology; 2019 May; 156(7):2097-2115.e2. PubMed ID: 30768986 [TBL] [Abstract][Full Text] [Related]
22. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma. Blair AB; Zheng L Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008 [TBL] [Abstract][Full Text] [Related]
23. Advances in immunotherapy for pancreatic cancer: 2013. DeVito NC; Saif MW JOP; 2013 Jul; 14(4):347-53. PubMed ID: 23846925 [TBL] [Abstract][Full Text] [Related]
24. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Niu L; Chen J; He L; Liao M; Yuan Y; Zeng J; Li J; Zuo J; Xu K Pancreas; 2013 Oct; 42(7):1143-9. PubMed ID: 23899940 [TBL] [Abstract][Full Text] [Related]
26. [Advances in immunotherapy of pancreatic ductal adenocarcinoma]. Yang JQ; Wei T; Chen YW; Bai XL; Liang TB Zhonghua Wai Ke Za Zhi; 2017 May; 55(5):396-400. PubMed ID: 28464583 [TBL] [Abstract][Full Text] [Related]
27. T cell optimization for the treatment of pancreatic cancer. Liu F; Saif MW Expert Opin Biol Ther; 2017 Dec; 17(12):1493-1501. PubMed ID: 28835191 [TBL] [Abstract][Full Text] [Related]
28. Towards immunotherapy for pancreatic cancer. Brett BT; Caplin ME Gut; 2000 Apr; 46(4):582-3. PubMed ID: 10798901 [No Abstract] [Full Text] [Related]
29. [Immunotherapy of cancers by inhibiting control of the immune response honored by a Nobel Prize]. Lebranchu Y Rev Prat; 2019 Mar; 69(3):243-246. PubMed ID: 30983244 [No Abstract] [Full Text] [Related]
31. [Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects]. Ye C; Zheng L; Yuan CH Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):10-15. PubMed ID: 30612387 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapy: Direct shot. Bird L Nat Rev Immunol; 2018 Mar; 18(3):149. PubMed ID: 29449701 [No Abstract] [Full Text] [Related]
33. Current Status of Immunotherapy Treatments for Pancreatic Cancer. Jimenez-Luna C; Prados J; Ortiz R; Melguizo C; Torres C; Caba O J Clin Gastroenterol; 2016; 50(10):836-848. PubMed ID: 27505403 [TBL] [Abstract][Full Text] [Related]
34. Immunotherapy: HLA genotype: good to be different. Minton K Nat Rev Immunol; 2018 Feb; 18(2):78-79. PubMed ID: 29279611 [No Abstract] [Full Text] [Related]
35. Immunotherapy: Relying on quality over quantity. Romero D Nat Rev Clin Oncol; 2018 Jan; 15(1):6-7. PubMed ID: 29182163 [No Abstract] [Full Text] [Related]
36. Immunotherapy for pancreatic cancer - science driving clinical progress. Laheru D; Jaffee EM Nat Rev Cancer; 2005 Jun; 5(6):459-67. PubMed ID: 15905855 [TBL] [Abstract][Full Text] [Related]
37. Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot". Bilusic M; Gulley JL J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 30053078 [No Abstract] [Full Text] [Related]
39. Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends. Cheung PF; Lutz M; Siveke JT Oncol Res Treat; 2018; 41(5):286-290. PubMed ID: 29705789 [TBL] [Abstract][Full Text] [Related]
40. iRECIST: A clarification of tumour response assessment in the immunotherapy era. Ferté C; Marabelle A Eur J Cancer; 2017 May; 77():165-167. PubMed ID: 28385325 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]